Funding

Nuevos marcadores metabólicos para la estratificación y manejo clínico del cáncer de páncreas. PI20/0942. IIS Aragon. 01/01/2021-31/12/2023. 129,000 €.
A novel metabolic exosomal signature in liquid biopsy to improve pancreatic cancer outcomes. IDEAS Semilla 2020. IIS Aragón.  01/12/2020-30/11/2022. 19960€
Contribution of fatty acid metabolism to the advanced and metastatic phenotype of pancreatic cancer. 19-0250. IIS Aragon. 07/2019-06/2022. 189,520 €.

Estudio del papel del metabolismo lipídico en cáncer de páncreas mediante ratones avatar establecidos a partir de biopsias sólidas y líquidas. PI17/0082. IIS Aragon. 01/2018-12/2020. 135,520 €

Past Funding

Metabolic regulation of the metastatic phenotype in pancreatic cancer. CP16/00121. IIS Aragon. 02/2017-02/2019. 121,500 €.
Metabolic profiling of liver metastasis to identify new therapeutic strategies for treatment
of metastatic Pancreatic Ductal Adenocarcinoma
. M547. Barts Cancer
Institute. 02/05/2016-31/12/2017. 20,775 €.
Targeting mitochondrial metabolism as the Achilles heel of cancer stem cells. 2015 Award Round. Barts Cancer Institute. 01/2016-12/2018. 220,724 €.
Single Cell Analysis of Circulating Tumour Cells. Development Fund from BCI. 04/2015-03/2016. 19,004 €